featured
Prospective Phase 2 Trial of Once-Weekly Hypofractionated Radiation Therapy for Low-Risk Adenocarcinoma of the Prostate
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Oncology
Prospective Phase 2 Trial of Once-Weekly Hypofractionated Radiation Therapy for Low-Risk Adenocarcinoma of the Prostate: Late Toxicities and Outcomes
Clin Oncol (R Coll Radiol) 2016 Jan 09;[EPub Ahead of Print], M Zimmermann, D Taussky, C Menkarios, É Vigneault, MC Beauchemin, JP Bahary, AAG Martin, LV Diaz de Bedoya, C LambertAdvanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.